Howard Hughes Medical Institute (D.W., N.S.M., R.D.P.) and
Departments of Biochemistry (D.W.) and Psychiatry and Behavioral
Sciences (P.S.), University of Washington, Seattle, Washington; and
Geriatric Research, Education, Clinical Center (GRECC), Puget Sound
Health Care System, Seattle, Washington (P.S.)
It has been known for many years that norepinephrine (NE) is a potent
endogenous anticonvulsant, yet there is confusion as to which
receptor(s) mediate this effect. This is probably due to
multiple factors, including the importance of distinct signaling pathways for different seizure paradigms, a lack of comprehensive pharmacological studies, and difficulty in interpreting existing pharmacological results due to the presence of endogenous NE. We sought
to circumvent these problems by testing the anticonvulsant activity of
selective agonists for most known adrenoreceptors (ARs) in dopamine
-hydroxylase knockout (Dbh
/
) mice that lack endogenous NE. Dbh
/
mice are hypersensitive to
pentylenetetrazole (PTZ)-induced seizures, demonstrating that
endogenous NE inhibits PTZ-induced seizures in the wild type.
Pretreatment of Dbh
/
mice with an
1AR or
2AR, but not an
2AR or
1AR agonist significantly protected against PTZ-induced seizures. In contrast, only the
2AR agonist showed anticonvulsant activity in
heterozygous controls. Furthermore, an
1AR antagonist
exacerbated PTZ-induced seizures in control mice, whereas a
2AR antagonist had no effect. We conclude that
activation of the
1AR is primarily responsible for the
anticonvulsant activity of endogenous NE in the murine PTZ model of
epilepsy. Endogenous NE probably does not activate the
2AR under these conditions, but exogenous activation of
the
2AR produces an anticonvulsant effect.
 |
Introduction |
The
importance of endogenous norepinephrine (NE) as an anticonvulsant
neurotransmitter is well established. For example, specific lesions of
the central noradrenergic system using 6-hydroxydopamine (Corcoran et al., 1974
) or
N-(2-chloroethyl)-N-2-bromobenzylamine (Carre and Harley, 1986
) result in increased seizure sensitivity. Conversely, stimulation of the locus coeruleus, the primary central noradrenergic nucleus, significantly inhibits seizures (Weiss et
al., 1990
). More recently, antiepileptic therapies used clinically have
been shown to either increase central NE content or require an intact
noradrenergic system for their efficacy (Waller and Buterbaugh, 1985
;
Baf et al., 1994
; Krahl et al., 1998
; P. Szot, D. Weinshenker,
J. M. Rho, T. W. Storey, and P. A. Schwartzkroin, unpublished
data). Despite the long-standing interest and experimentation along these lines, it is still unclear exactly how NE inhibits seizure
activity. There are three primary reasons for this confusion.
First, the noradrenergic signaling system is extremely complex; three
distinct classes of receptor with multiple subtypes have been cloned,
and each class activates different G proteins. The
1 class of adrenoreceptors (ARs) is linked to
Go/Gq and activates phospholipase C and intracellular Ca2+ release.
2ARs are linked to Gi
and inhibit adenylate cyclase.
ARs (
1AR and
2AR) are linked to Gs
and activate adenylate cyclase (for review, see Cooper et al., 1996
).
All of these receptor classes are widely distributed throughout the
brain and are found in regions implicated in regulating seizures such
as the hippocampus, cortex, and amygdala. Differences in receptor
distribution between animal species, strain, and the brain region(s)
affected by seizure-inducing paradigms probably contribute to the
variety of ARs shown to possess anticonvulsant activity (Papanicolaou
et al., 1982
; Lints and Nyquist-Battie, 1985
; Neuman, 1986
;
Löscher and Czuczwar, 1987
; Ferraro et al., 1994
; Yan et al.,
1998
). Second, despite this complexity, many seizure susceptibility
studies have not been pharmacologically comprehensive for any given
seizure paradigm. For example, data have been presented exclusively on
nonselective
AR antagonists (Lints and Nyquist-Battie, 1985
),
nonselective
AR agonists and antagonists (Ferraro et al., 1994
), and
AR agonists and antagonists (Löscher and Czuczwar, 1987
; Tsuda
et al., 1990
). In only a few studies have compounds that target both
ARs and
ARs been tested (Neuman, 1986
; Gellman et al., 1987
;
Micheletti et al., 1987
), and even these were somewhat limited in their scope.
Third, although the
2AR receptor is probably
the most promiscuous anticonvulsant receptor in terms of efficacy
across species, strain, and seizure paradigm (Papanicolaou et al.,
1982
; Baran et al., 1985
; Scotti de Carolis et al., 1986
; Löscher
and Czuczwar, 1987
; Jackson et al., 1991
), proconvulsant effects have
also been reported (Oishi et al., 1979
; Löscher and Czuczwar,
1987
; Wu et al., 1987
). In addition, there are inherent difficulties
interpreting any of these results. Three different subtypes of
2AR exist (
2A,
2B, and
2C) and they
are localized both pre- and postsynaptically. Activation of presynaptic
2AR autoreceptors decreases noradrenergic firing and NE release (L'Heureux et al., 1986
; Jorm and Stamford, 1993
), while activation of postsynaptic
2ARs
mimics the effect of released NE on target cells expressing these
receptors and inhibits their firing (Gobert et al., 1998
). Because
available
2AR agonists cannot distinguish
between
2AR subtypes or pre- versus
postsynaptic
2ARs, it is nearly impossible to
interpret the effect of
2AR agonists. In
addition, there is some evidence that activation of presynaptic
ARs
facilitate central NE release (Murugaiah and O'Donnell (1995)
.
To address these issues, we have tested the effects of
subtype-selective agonists and antagonists for most known ARs on
susceptibility to pentylenetetrazole (PTZ)-induced seizures in dopamine
-hydroxylase knockout (Dbh
/
) mice that are deficient
in NE synthesis and lack NE, thereby isolating the postsynaptic effects
of these compounds and eliminating any influence on NE release.
Dbh
/
mice have increased susceptibility to PTZ-induced
seizures, demonstrating that endogenous NE is anticonvulsant in this
model of epilepsy (Szot et al., 1999
). Both anticonvulsant
(Löscher and Czuczwar, 1987
; Amabeoku et al., 1994
) and
proconvulsant (Oishi et al., 1979
; Fletcher and Forster, 1988
) effects
of clonidine on PTZ-induced seizures in mice have been reported. We
predicted that the effects of clonidine would be abolished in Dbh
/
mice if it acts via presynaptic
2ARs, but Dbh
/
mice would
still be affected if the postsynaptic
2ARs are involved.
 |
Materials and Methods |
Animals.
Dbh knockout (Dbh
/
)
mice, maintained on a 129/SvEv and C57BL/6J hybrid background, were
developed and generated as described (Thomas et al., 1998
). Mice were
reared in a specific pathogen-free facility with a 12-h light/dark
cycle at the University of Washington (Seattle, WA), but moved to a
conventional facility for seizure experiments. Mice between 3 and 6 months of age were used for all experiments, and food and water were
available ad libitum.
Dbh
/
mice were identified by the delayed growth and
ptosis phenotype, which is 100% correlated with the Dbh
/
genotype (data not shown). A subset of genotypes was
confirmed by polymerase chain reaction. Dbh +/
mice have
normal levels of epinephrine and NE and are indistinguishable from
wild-type littermates for all previously tested behaviors, including
seizure susceptibility (Thomas et al., 1998
; Szot et al., 1999
).
Therefore, heterozygous (Dbh +/
) littermates were used as
controls for all experiments in this study. Experimental
protocols were approved by the animal care committee at the University
of Washington and meet the guidelines of the American Association for
Accreditation of Laboratory Animal Care.
Seizure Induction.
Seizures were induced with an i.p.
injection of PTZ dissolved in water. Because Dbh
/
mice
are more sensitive to PTZ-induced seizures (Fig.
1; Szot et al., 1999
), doses of PTZ were
adjusted based on genotype in many experiments to elicit seizures of
similar severity in Dbh +/
and Dbh
/
mice.
PTZ was administered at a dose of 25, 30, or 40 mg/kg (6.25, 7.5, or 10 mg/ml) for Dbh
/
mice and 40 or 50 mg/kg (10 or 12.5 mg/ml) for Dbh +/
mice in a volume of 4 ml/kg. The lower
doses of PTZ for each genotype, which produced mild seizures, were used
when testing a drug that had a proconvulsant effect based on pilot
experiments, while the higher doses produced severe seizures and were
used when testing anticonvulsant compounds. Mice were placed in a clear
Plexiglas chamber and closely observed for 10 min. This observation
time was chosen because mice that displayed seizure activity did so within the first few minutes after PTZ administration and were typically postictal by 10 min. Latency to first myoclonic jerk (MJ) and
clonic/tonic (C/T) seizure was recorded. Animals that did not
experience one of these behavioral seizure landmarks were assigned a
latency of 600 s for that measurement.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 1.
Susceptibility of Dbh +/ and
Dbh / mice to PTZ-induced seizures. Shown are
latencies to first MJ and C/T seizure. These data are a compilation of
results with water and vehicle-injected mice followed by administration
of 40 mg/kg PTZ from Figs. 2 through 4 (Dbh +/ ,
n = 49; Dbh / ,
n = 67). ****P < 0.0001 compared with Dbh +/ .
|
|
To test the effects of AR agonists and antagonists, clonidine,
yohimbine, phenylephrine, cirazoline, isoproterenol, dobutamine, albuterol, prazosin, propanolol, ICI-118,551, or idazoxan (Sigma, St.
Louis, MO) were administered intraperitoneally in a volume of 4 ml/kg
30 min prior to seizure induction with PTZ. To test the ability of an
antagonist to block the anticonvulsant activity of an agonist, the
antagonist was administered 30 min prior to the agonist. All drugs were
dissolved in water with the exception of prazosin, which was dissolved
in a mixture of 1.5% DMSO and 1.5% Cremaphor EL (Sigma). For prazosin
experiments, the DMSO/Cremaphor EL solution was used as a vehicle
control. Water was used as a vehicle control for all other experiments.
Drug doses were based on those used in the murine seizure literature
when available, and on published rat data or pilot experiments when a
compound had not been previously test in mice.
Data were analyzed using Student's t tests for comparing
two groups with means of equivalent variance, Mann-Whitney U
tests for comparing two groups with means of nonequivalent variance, and analysis of variance followed by Newman-Keuls post hoc tests for
comparing means from more than two groups. P < 0.05 was considered significant.
 |
Results |
Dbh
/
Mice Are Hypersensitive to PTZ-Induced
Seizures.
We previously reported that Dbh
/
mice
have shorter latencies to first MJ and C/T seizure than Dbh
+/
mice following PTZ administration (Szot et al., 1999
). We
repeated this experiment with a larger number of mice and obtained the
same result (Fig. 1), demonstrating that a lack of endogenous NE
results in increased sensitivity to PTZ-induced seizures.
2AR Agonists Act via Autoreceptors to Exacerbate
PTZ-Induced Seizures.
To determine whether
2AR agonists increased or decreased
sensitivity to PTZ-induced seizures, we treated Dbh +/
mice with the
2AR agonist clonidine prior to
PTZ administration. Clonidine (0.1 mg/kg) had a proconvulsant effect
that was most pronounced for latency to MJ (Fig.
2A). To determine whether this
proconvulsant effect was mediated by an inhibition of NE release via
presynaptic autoreceptors or via actions on postsynaptic
heteroreceptors, we tested the effect of clonidine on PTZ-induced
seizures in Dbh
/
mice. Clonidine did not alter seizure
latency in Dbh
/
mice in response to 30 mg/kg PTZ (Fig.
2A) or 25 mg/kg PTZ (latency to MJ: vehicle = 317 ± 73 s, 0.1 mg/kg clonidine = 265 ± 29 s, P = 0.85; no C/T seizures observed), suggesting that the proconvulsant effect seen in control mice resulted from decreased NE release mediated
by activation of presynaptic
2AR
autoreceptors. Clonidine treatment caused piloerection in both
genotypes and rescued the bilateral ptosis phenotype of Dbh
/
mice, demonstrating that the drug possessed biological
activity at this dose in the knockouts (data not shown). Blockade of
2ARs with yohimbine (10 mg/kg) slightly
increased seizure latency in both genotypes, but the effect was not
significant (Fig. 2B). The weak anticonvulsant effect of yohimbine may
have been nonspecific and caused by the significant sedation observed
with this treatment. The
2AR antagonist idazoxan (3 mg/kg), which lacks the sedative effects of yohimbine, also
did not have a significant effect (data not shown). These results
suggest that while exogenous activation of
2ARs can exacerbate PTZ-induced seizures,
activation of
2ARs by endogenous NE is not
involved under these conditions.

View larger version (44K):
[in this window]
[in a new window]
|
Fig. 2.
Effects of 2AR-acting drugs on
PTZ-induced seizure susceptibility. Shown are latencies to first MJ and
C/T seizure. A, water (Dbh +/ , n = 13; Dbh / , n = 14) or clonidine
(0.1 mg/kg: Dbh +/ , n = 14;
Dbh / , n = 14) was administered
30 min prior to PTZ (40 mg/kg for Dbh +/ , 30 mg/kg for
Dbh / ). *P < 0.05 compared with
water control. B, water (Dbh +/ , n = 12; Dbh / , n = 8) or yohimbine
(10 mg/kg: Dbh +/ , n = 12;
Dbh / , n = 8) was administered
30 min prior to PTZ (50 mg/kg for Dbh +/ , 40 mg/kg for
Dbh / ).
|
|
Activation of Central
1ARs Inhibits PTZ-Induced
Seizures in Dbh
/
Mice.
While clonidine is a
fairly selective
2AR agonist, it has some
activity at
1ARs at high doses (Wu et al.,
1987
). We considered the possibility that our results with clonidine
were due to concurrent activation of
1ARs, but
rejected this hypothesis based on the results of two experiments.
First, decreasing the dose of clonidine to 1 µg/kg failed to reveal
an anticonvulsant effect (data not shown). This dose was chosen because
it is maximally effective at inhibiting PTZ-induced seizures in normal
rats and electrically induced seizures in rats with 6-hydroxydopamine
lesions of their noradrenergic systems (Dalton et al., 1985
). Second,
cirazoline (0.2 mg/kg), a selective
1AR
agonist, significantly increased latencies to MJ and C/T seizures in
Dbh
/
mice (Fig. 3A).
While eight of nine vehicle-treated Dbh
/
mice
progressed to a C/T seizure at this dose of PTZ, only 2 of 10 cirazoline-treated Dbh
/
mice had seizures of this
severity. Similar effects were obtained with 0.1 and 0.5 mg/kg
cirazoline (data not shown). This anticonvulsant effect was blocked by
pretreatment with prazosin (1 mg/kg), a selective
1AR antagonist, further verifying the
importance of
1ARs (Fig. 3B). While cirazoline
did not have a significant anticonvulsant effect on Dbh +/
controls (Fig. 3A), prazosin alone (1 mg/kg) had a proconvulsant effect
(Fig. 3C), reducing latencies to MJ and C/T seizures. These data
suggest that the inhibition of seizures by endogenous NE in normal
animals involves
1ARs.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 3.
Effects of 1AR-acting drugs on
PTZ-induced seizure susceptibility. Shown are latencies to first MJ and
C/T seizure. A, water (n = 8 for each genotype) or
cirazoline (0.2 mg/kg: Dbh +/ , n = 8; Dbh / , n = 9) was
administered 30 min prior to PTZ (50 mg/kg for Dbh +/ ,
40 mg/kg for Dbh / ). *P < 0.05 compared with water control; **P < 0.01 compared with water
control. B, vehicle (1.5% DMSO, 1.5% Cremaphor EL in water) or
prazosin (1 mg/kg) was administered 30 min prior to water or cirazoline
(0.2 mg/kg; n = 10 for each drug treatment group),
which was administered to Dbh / mice 30 min prior to
PTZ (40 mg/kg). *P < 0.05 compared with water
control. ***P < 0.001 compared with water control.
P < 0.01 compared with cirazoline
alone. C, vehicle (1.5% DMSO, 1.5% Cremaphor EL in water) or prazosin
(1 mg/kg; n = 12 for each drug treatment group) was
administered to Dbh +/ mice 30 min prior to PTZ (40 mg/kg). *P < 0.05 compared with vehicle control;
**P < 0.01 compared with vehicle control. D, water
(n = 6) or phenylephrine (3 mg/kg;
n = 7) was administered to Dbh /
mice 30 min prior to PTZ (40 mg/kg).
|
|
Because
1AR agonists have profound effects on
the peripheral nervous system, we determined whether the anticonvulsant
effect of cirazoline was mediated by central or peripheral
1 receptors. In contrast to cirazoline,
phenylephrine (3 mg/kg), an
1AR agonist that
cannot cross the blood-brain barrier, failed to inhibit seizures in
Dbh
/
mice (Fig. 3D) despite having qualitatively
similar effects on ptosis and piloerection (data not shown). These
results suggest that Dbh
/
mice are more susceptible to
PTZ-induced seizures at least in part because of a lack of central
1AR signaling.
2AR Signaling Inhibits PTZ-Induced Seizures.
To
investigate the contribution of
AR signaling to the anticonvulsant
effect of NE, we treated mice with isoproterenol, a nonselective
AR
agonist. We found that isoproterenol (10 mg/kg) increased latencies to
PTZ-induced seizures in both Dbh
/
and Dbh
+/
mice (Fig. 4A). To determine
which
AR subtype was responsible for the anticonvulsant effect of
isoproterenol, mice were treated with a preferential
1AR (dobutamine) or a preferential
2AR (albuterol) agonist prior to PTZ
administration. While dobutamine (10 mg/kg) did not significantly
affect seizure susceptibility in Dbh
/
mice, albuterol
(10 mg/kg) prolonged the latency to both MJ and C/T seizures (Fig. 4B).
Nearly all water-treated Dbh
/
mice (22 of 23)
progressed to C/T seizures, while only 6 of 22 albuterol-treated Dbh
/
mice had seizures of that severity (data from Fig.
4, B and C, combined). Albuterol also significantly protected Dbh +/
control mice (Fig. 4B). Propanolol (10 mg/kg), a nonselective
AR antagonist, blocked the anticonvulsant effect of albuterol in
terms of latency to MJ but not C/T seizure in Dbh
/
mice (Fig. 4C). To determine whether the inability of propanolol to completely block the anticonvulsant effect of albuterol was due to
blockade of
1ARs as well as
2ARs, we tested the
2AR-selective antagonist ICI-118,551.
ICI-118,551 (10 mg/kg) abolished the anticonvulsant effect of albuterol
on MJ, but only partially blocked its effect on C/T seizures (Fig. 4C).
Nadolol (10 mg/kg), a nonselective
AR antagonist that cannot cross
the blood-brain barrier, had effects similar to ICI-118,551 (Fig. 4C).
Last, neither propanolol (10, 20, or 40 mg/kg) nor ICI-118,551 affected
susceptibility to PTZ-induced seizures in Dbh +/
control
mice (Fig. 4D; data not shown). These results suggest that
2ARs do not mediate the anticonvulsant effect
of endogenous NE, but that exogenous activation of
2ARs can inhibit PTZ-induced seizures in mice.

View larger version (40K):
[in this window]
[in a new window]
|
Fig. 4.
Effects of AR-acting drugs on PTZ-induced seizure
susceptibility. Shown are latencies to first MJ and C/T seizure. A,
water (Dbh +/ , n = 10; Dbh
/ , n = 9) or isoproterenol (10 mg/kg:
Dbh +/ , n = 10; Dbh
/ , n = 9) was administered 30 min prior
to PTZ (50 mg/kg for Dbh +/ , 40 mg/kg for Dbh
/ ). *P < 0.05 compared with water
control. **P < 0.01 compared with water control.
****P < 0.0001 compared with water control. B,
water (Dbh +/ , n = 9; Dbh
/ , n = 13), albuterol (10 mg/kg:
Dbh +/ , n = 9; Dbh
/ , n = 5), or dobutamine (10 mg/kg:
Dbh / , n = 8) was administered
30 min prior to PTZ (50 mg/kg for Dbh +/ , 40 mg/kg for
Dbh / ). **P < 0.01 compared
with water control. ***P < 0.001 compared with
water control. C, water, propanolol (10 mg/kg), ICI-118,551 (10 mg/kg),
or nadolol (10 mg/kg) was administered 30 min prior to water or
albuterol (10 mg/kg), which was administered to Dbh
/ mice (water + water, n = 18; water + albuterol, n = 17; propanolol + albuterol,
n = 9; ICI-118,551 + albuterol,
n = 12; nadolol + albuterol, n = 16) 30 min prior to PTZ (40 mg/kg). *P < 0.05 compared with water control. **P < 0.01 compared
with water control. ***P < 0.001 compared with
water control. P < 0.05 compared
with albuterol alone.  P < 0.01 compared with albuterol alone. D, water, propanolol (10 mg/kg), or
ICI-118,551 (10 mg/kg) was administered to Dbh +/ mice
(n = 10 for each drug treatment group) 30 min prior
to PTZ (40 mg/kg).
|
|
 |
Discussion |
The results of this study are summarized in Table
1 and reveal three important points.
First, stimulation of
2ARs has a proconvulsant
effect on PTZ-induced seizures. This effect is probably mediated by the
inhibition of NE release via presynaptic
2
autoreceptors, because the proconvulsant effect is abolished in
Dbh
/
mice. Second, stimulation of either
1ARs or
2 ARs
restores normal PTZ-induced seizure susceptibility upon Dbh
/
mice. Third,
1AR but not
2AR antagonists confer increased seizure
susceptibility upon control mice, suggesting that endogenous NE
inhibits seizures by activating
1ARs in
animals with normal NE content.
View this table:
[in this window]
[in a new window]
|
TABLE 1
Summary of AR agonist and antagonist effects on PTZ-induced seizure
susceptibility
Dbh / mice are more susceptible to PTZ-induced seizures
than Dbh +/ controls, and some AR agonists and antagonists
affect susceptibility differently in the two genotypes. represents
an increase in latency, represents a decrease in latency, and represents no change in latency to PTZ-induced seizure compared with
the no drug control for each genotype.
|
|
Role of
2ARs in PTZ Seizures.
The literature
indicates that
2ARs are the most likely
receptor type to mediate the anticonvulsant effect of endogenous NE to
PTZ-induced seizures in rats. Multiple independent investigators have
found that
2AR agonists inhibit PTZ-induced
seizures (Papanicolaou et al., 1982
; Scotti de Carolis et al., 1986
;
Löscher and Czuczwar, 1987
), and that
2AR antagonists block the anticonvulsant
effect of
2AR agonists and potentiate
PTZ-induced seizures on their own (Lazarova and Samanin, 1983
; Scotti
de Carolis et al., 1986
). Because endogenous NE is anticonvulsant, the
interpretation of these results was that the anticonvulsant effect of
2AR agonists was mediated by postsynaptic
receptors. However, one of the earliest publications on this theme
reported a proconvulsant effect of clonidine on PTZ-induced seizures in
mice, and proposed that activation of presynaptic
2ARs decreased NE release and exacerbated
seizures (Oishi et al., 1979
). Since then, both proconvulsant (Fletcher and Forster, 1988
) and anticonvulsant (Löscher and Czuczwar, 1987
; Amabeoku et al., 1994
) effects of clonidine in mice have been
reported. We undertook this study using Dbh
/
mice that lack endogenous NE to determine whether clonidine is pro- or
anticonvulsant and whether these effects are mediated by pre- or
postsynaptic
2ARs. We found that clonidine has
a proconvulsant effect on control mice but no effect on Dbh
/
mice, suggesting that in our paradigm clonidine decreases NE
release via presynaptic
2ARs in normal animals.
Clonidine has been shown to have an anticonvulsant effect in models
where seizures were induced by kainic acid (Baran et al., 1985
),
amygdala kindling (Gellman et al., 1987
; Löscher and Czuczwar, 1987
), and air blast stimulation (Löscher and Czuczwar, 1987
). However, clonidine has exhibited proconvulsant effects in others, such
as electroconvulsions (Löscher and Czuczwar, 1987
), quinolinic acid (Wu et al., 1987
), and spontaneous petit mal seizures (Micheletti et al., 1987
). In fact, clonidine has a proconvulsant effect in humans
with intractable focal epilepsies (Kirchberger et al., 1998
). One
explanation for these conflicting results is that these diverse
seizure-inducing paradigms involve distinct mechanisms and different
brain regions, and therefore the effect of
2AR agonists and antagonists varies with
2AR
distribution and function, species, and strain. Because endogenous NE
is anticonvulsant in most seizure-inducing paradigms, we hypothesize
that the proconvulsant effects seen with clonidine are mediated by
2AR autoreceptors, while the anticonvulsant
effects observed are mediated by
2AR heteroreceptors on target neurons.
Role of
1ARs in PTZ Seizures.
There are three
results that support our conclusion that
1AR
activation mediates the anticonvulsant effects of endogenous NE in
PTZ-induced seizures. First, Dbh
/
mice that lack
endogenous NE are hypersensitive to PTZ-induced seizures, and
administration of an
1AR-selective agonist can
restore normal sensitivity. Second, inhibition of PTZ-induced seizures
by cirazoline can be blocked by prazosin, a selective
1AR antagonist. Third, prazosin administration in control mice results in increased PTZ sensitivity. The inability of
cirazoline to significantly protect Dbh +/
mice may mean
that
1ARs are already maximally activated in
normal animals during seizures. Although
1ARs
have not previously been implicated in PTZ-induced seizures
(Löscher and Czuczwar, 1987
),
1 agonists have anticonvulsant activity in many other seizure models, including amygdala kindling (Löscher and Czuczwar, 1987
), air blast
stimulation (Löscher and Czuczwar, 1987
), focal cortical
penicillin (Neuman, 1986
), audiogenic seizures (Yan et al., 1998
),
quinolinic acid (Wu et al., 1987
), and spontaneous petit mal seizures
(Micheletti et al., 1987
). Further evidence that
1ARs mediate the anticonvulsant effect of
endogenous NE in some situations comes from studies showing changes in
1AR density in seizure-sensitive rats
(Nicoletti et al., 1986
; Gundlach et al., 1995
), mice (Jazrawi and
Horton, 1986
), and humans with epilepsy (Brière et al., 1986
).
Role of
2ARs in PTZ Seizures.
Our results
indicate that activation of
2ARs, but not
1ARs, inhibits PTZ-induced seizures in both
norepinephrine-deficient Dbh
/
mice and Dbh
+/
mice, which have normal NE content. Because mice lacking NE
were affected, we conclude that albuterol exerts its anticonvulsant
action via postsynaptic
2ARs and does not involve an increase in NE release via presynaptic
2ARs. The lack of a proconvulsant effect of
the
AR antagonists propanolol or ICI-118,551 on Dbh +/
mice suggests that
2ARs do not mediate the
anticonvulsant effect of endogenous NE, even though
2AR agonists can have an anticonvulsant affect
on mice with normal NE content. In fact, it is unclear whether
endogenously released NE typically activates
2ARs in the brain. For example,
2ARs have a much lower affinity than
1ARs for NE (for review, see Molinoff, 1984
).
1AR but not
2AR
antagonists affect behavior (Pandey et al., 1995
) and only
1ARs undergo changes in response to treatments
that chronically alter synaptic NE (Minneman et al., 1982
). However, exogenously supplied
2AR agonists affect
behavior,
2AR density (O'Donnell, 1990
), and
NE release (Murugaiah and O'Donnell, 1995
), suggesting that
2ARs are functional when artificially
stimulated, as they appear to be in our study.
The anticonvulsant site of action of albuterol remains unresolved.
While all of the
2AR antagonists exhibited the
ability to reverse the effect of albuterol on latency to MJ, none were especially efficacious at blocking its effects on generalized C/T
seizures. The fact that isoproterenol and nadolol, which are reported
not to cross the blood-brain barrier, had any effect suggests that
albuterol is acting at least partially via a peripheral mechanism.
Because NE has profound effects on the cardiovascular system, it is
possible that these drugs are exerting their effects on seizures by
modulating heart rate or blood pressure. However, an alternative
explanation is that these drugs may get into the brain when
administered peripherally at high doses. For example, i.p.
administration of 1 mg/kg isoproterenol results in a substantial increase in phosphorylation of Ca2+ channels in
the central nervous system (J. Hell, personal communication). Comparison of the anticonvulsant effects of central versus peripheral albuterol administration will help resolve this issue. The inability of
any
AR antagonist to completely block the anticonvulsant effect of
albuterol may be related to relative doses, receptor affinities, and
blood-brain barrier permeability.
 |
Conclusions |
This study comprehensively examines the anticonvulsant
pharmacology of NE for a single convulsant agent, PTZ. The use of
Dbh
/
mice, which lack NE, circumvents many of the
caveats in the interpretation of results obtained in the presence of
endogenous NE, and provides an example of how a combination of genetics
and pharmacology can be a powerful approach in the study of
neurotransmitter function.
It is important to note that each class of convulsant agent probably
elicits seizures by distinct mechanisms that most likely involve
different regions of the brain. Therefore, it is not surprising that
there is not one "universal" noradrenergic receptor that mediates
the anticonvulsant effect of NE for all seizure models. Because
Dbh
/
mice are also more susceptible to seizures induced by kainic acid, flurothyl, and sound (Szot et al., 1999
), it will be
possible to apply the same approach to the identification of the
anticonvulsant NE receptor(s) involved in other seizure models.
Accepted for publication May 25, 2001.
Received for publication April 5, 2001.
D.W. and N.S.M. were supported by the Howard Hughes Medical
Institute. P.S. was supported by the National Alliance for Research on
Schizophrenia and Depression and the Department of Veterans Affairs.
NE, norepinephrine;
AR, adrenoreceptor;
PTZ, pentylenetetrazole;
Dbh, dopamine
-hydroxylase;
MJ, myoclonic jerk;
C/T, clonic/tonic;
DMSO, dimethyl sulfoxide.